87 related articles for article (PubMed ID: 11133770)
1. Combined effect of all-trans retinoic acid and arsenic trioxide in acute promyelocytic leukemia cells in vitro and in vivo.
Jing Y; Wang L; Xia L; Chen GQ; Chen Z; Miller WH; Waxman S
Blood; 2001 Jan; 97(1):264-9. PubMed ID: 11133770
[TBL] [Abstract][Full Text] [Related]
2. Arsenic trioxide, a therapeutic agent for APL.
Zhang TD; Chen GQ; Wang ZG; Wang ZY; Chen SJ; Chen Z
Oncogene; 2001 Oct; 20(49):7146-53. PubMed ID: 11704843
[TBL] [Abstract][Full Text] [Related]
3. Targeting expression of the leukemogenic PML-RARα fusion protein by lentiviral vector-mediated small interfering RNA results in leukemic cell differentiation and apoptosis.
Ward SV; Sternsdorf T; Woods NB
Hum Gene Ther; 2011 Dec; 22(12):1593-8. PubMed ID: 21846246
[TBL] [Abstract][Full Text] [Related]
4. Retinoic acid and arsenic synergize to eradicate leukemic cells in a mouse model of acute promyelocytic leukemia.
Lallemand-Breitenbach V; Guillemin MC; Janin A; Daniel MT; Degos L; Kogan SC; Bishop JM; de Thé H
J Exp Med; 1999 Apr; 189(7):1043-52. PubMed ID: 10190895
[TBL] [Abstract][Full Text] [Related]
5. As(2)O(3) enhances retroviral reverse transcription and counteracts Ref1 antiviral activity.
Berthoux L; Towers GJ; Gurer C; Salomoni P; Pandolfi PP; Luban J
J Virol; 2003 Mar; 77(5):3167-80. PubMed ID: 12584341
[TBL] [Abstract][Full Text] [Related]
6. Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): I. As2O3 exerts dose-dependent dual effects on APL cells.
Chen GQ; Shi XG; Tang W; Xiong SM; Zhu J; Cai X; Han ZG; Ni JH; Shi GY; Jia PM; Liu MM; He KL; Niu C; Ma J; Zhang P; Zhang TD; Paul P; Naoe T; Kitamura K; Miller W; Waxman S; Wang ZY; de The H; Chen SJ; Chen Z
Blood; 1997 May; 89(9):3345-53. PubMed ID: 9129041
[TBL] [Abstract][Full Text] [Related]
7. Heme Oxygenase-1 Inhibition Modulates Autophagy and Augments Arsenic Trioxide Cytotoxicity in Pancreatic Cancer Cells.
Ahmad IM; Dafferner AJ; Salloom RJ; Abdalla MY
Biomedicines; 2023 Sep; 11(9):. PubMed ID: 37761021
[TBL] [Abstract][Full Text] [Related]
8. All-trans retinoic acid enhances the cytotoxic effect of decitabine on myelodysplastic syndromes and acute myeloid leukaemia by activating the RARα-Nrf2 complex.
Wang L; Zhang Q; Ye L; Ye X; Yang W; Zhang H; Zhou X; Ren Y; Ma L; Zhang X; Mei C; Xu G; Li K; Luo Y; Jiang L; Lin P; Zhu S; Lang W; Wang Y; Shen C; Han Y; Liu X; Yang H; Lu C; Sun J; Jin J; Tong H
Br J Cancer; 2023 Feb; 128(4):691-701. PubMed ID: 36482192
[TBL] [Abstract][Full Text] [Related]
9. Revisiting Platinum-Based Anticancer Drugs to Overcome Gliomas.
Jeon J; Lee S; Kim H; Kang H; Youn H; Jo S; Youn B; Kim HY
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34065991
[TBL] [Abstract][Full Text] [Related]
10. Evolving Chemotherapy Free Regimens for Acute Promyelocytic Leukemia.
Kulkarni U; Mathews V
Front Oncol; 2021; 11():621566. PubMed ID: 33718181
[TBL] [Abstract][Full Text] [Related]
11. SUMOylation disassembles the tetrameric pyruvate kinase M2 to block myeloid differentiation of leukemia cells.
Xia L; Jiang Y; Zhang XH; Wang XR; Wei R; Qin K; Lu Y
Cell Death Dis; 2021 Jan; 12(1):101. PubMed ID: 33473116
[TBL] [Abstract][Full Text] [Related]
12. Acute Promyelocytic Leukemia: A History over 60 Years-From the Most Malignant to the most Curable Form of Acute Leukemia.
Thomas X
Oncol Ther; 2019 Jun; 7(1):33-65. PubMed ID: 32700196
[TBL] [Abstract][Full Text] [Related]
13. Targeting the TR4 nuclear receptor-mediated lncTASR/AXL signaling with tretinoin increases the sunitinib sensitivity to better suppress the RCC progression.
Shi H; Sun Y; He M; Yang X; Hamada M; Fukunaga T; Zhang X; Chang C
Oncogene; 2020 Jan; 39(3):530-545. PubMed ID: 31501521
[TBL] [Abstract][Full Text] [Related]
14. Retinoic acid and arsenic trioxide induce lasting differentiation and demethylation of target genes in APL cells.
Huynh TT; Sultan M; Vidovic D; Dean CA; Cruickshank BM; Lee K; Loung CY; Holloway RW; Hoskin DW; Waisman DM; Weaver ICG; Marcato P
Sci Rep; 2019 Jul; 9(1):9414. PubMed ID: 31263158
[TBL] [Abstract][Full Text] [Related]
15. Targeting miR-193a-AML1-ETO-β-catenin axis by melatonin suppresses the self-renewal of leukaemia stem cells in leukaemia with t (8;21) translocation.
Zhou B; Ye H; Xing C; Liang B; Li H; Chen L; Huang X; Wu Y; Gao S
J Cell Mol Med; 2019 Aug; 23(8):5246-5258. PubMed ID: 31119862
[TBL] [Abstract][Full Text] [Related]
16. Filomicelles Deliver a Chemo-Differentiation Combination of Paclitaxel and Retinoic Acid That Durably Represses Carcinomas in Liver to Prolong Survival.
Nair PR; Alvey C; Jin X; Irianto J; Ivanovska I; Discher DE
Bioconjug Chem; 2018 Apr; 29(4):914-927. PubMed ID: 29451777
[TBL] [Abstract][Full Text] [Related]
17. From conventional therapy toward microRNA-based therapy in acute promyelocytic leukemia.
Ehtesham N; Sharifi M
Adv Biomed Res; 2016; 5():187. PubMed ID: 28028527
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcome of acute promyelocytic leukemia treated with all-
Abaza Y; Kantarjian H; Garcia-Manero G; Estey E; Borthakur G; Jabbour E; Faderl S; O'Brien S; Wierda W; Pierce S; Brandt M; McCue D; Luthra R; Patel K; Kornblau S; Kadia T; Daver N; DiNardo C; Jain N; Verstovsek S; Ferrajoli A; Andreeff M; Konopleva M; Estrov Z; Foudray M; McCue D; Cortes J; Ravandi F
Blood; 2017 Mar; 129(10):1275-1283. PubMed ID: 28003274
[TBL] [Abstract][Full Text] [Related]
19. Selective Impairment of TH17-Differentiation and Protection against Autoimmune Arthritis after Overexpression of BCL2A1 in T Lymphocytes.
Iglesias M; Augustin JJ; Alvarez P; Santiuste I; Postigo J; Merino J; Merino R
PLoS One; 2016; 11(7):e0159714. PubMed ID: 27433938
[TBL] [Abstract][Full Text] [Related]
20. Targeting of leukemia-initiating cells in acute promyelocytic leukemia.
Testa U; Lo-Coco F
Stem Cell Investig; 2015; 2():8. PubMed ID: 27358876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
